Ignite Creation Date:
2025-12-24 @ 2:56 PM
Ignite Modification Date:
2025-12-25 @ 5:28 PM
Study NCT ID:
NCT01616459
Status:
COMPLETED
Last Update Posted:
2019-07-16
First Post:
2012-06-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Immunogenicity and Safety of Two Formulations of GSK Biologicals' Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy Infants
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-07-11
Start Date Type:
ACTUAL
Primary Completion Date:
2013-04-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-01-22
Completion Date Type:
ACTUAL
First Submit Date:
2012-06-07
First Submit QC Date:
None
Study First Post Date:
2012-06-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-04-10
Results First Submit QC Date:
None
Results First Post Date:
2014-06-16
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2013-08-30
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2019-07-02
Last Update Post Date:
2019-07-16
Last Update Post Date Type:
ACTUAL